COPD-iNET: 呼吁肺病界采取行动,抗击 COPD 在全球的流行

IF 16.6 1区 医学 Q1 RESPIRATORY SYSTEM European Respiratory Journal Pub Date : 2024-09-26 DOI:10.1183/13993003.00921-2024
Ali Önder Yildirim, Thomas M. Conlon, Ian M. Adcock, Reinoud Gosens, Mareike Lehmann, Theodore S. Kapellos, Yohannes Tesfaigzi, Francesca Polverino, Maor Sauler, Roxana Wasnick, Enid Rose Neptune
{"title":"COPD-iNET: 呼吁肺病界采取行动,抗击 COPD 在全球的流行","authors":"Ali Önder Yildirim, Thomas M. Conlon, Ian M. Adcock, Reinoud Gosens, Mareike Lehmann, Theodore S. Kapellos, Yohannes Tesfaigzi, Francesca Polverino, Maor Sauler, Roxana Wasnick, Enid Rose Neptune","doi":"10.1183/13993003.00921-2024","DOIUrl":null,"url":null,"abstract":"<sec><st>Extract</st>\n<p>COPD is an increasingly prevalent, progressive and often debilitating lung disease, currently the third leading cause of death globally. While commonly considered a disease of smokers, common causes of COPD also include environmental pollution, infection, pre- and peri-natal life insults, and genetic predisposition [1, 2]. Current therapies are limited to reducing the burden of symptoms or exacerbations, but do not fundamentally alter the trajectory of the disease.</p>\n</sec>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"8 1","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD\",\"authors\":\"Ali Önder Yildirim, Thomas M. Conlon, Ian M. Adcock, Reinoud Gosens, Mareike Lehmann, Theodore S. Kapellos, Yohannes Tesfaigzi, Francesca Polverino, Maor Sauler, Roxana Wasnick, Enid Rose Neptune\",\"doi\":\"10.1183/13993003.00921-2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<sec><st>Extract</st>\\n<p>COPD is an increasingly prevalent, progressive and often debilitating lung disease, currently the third leading cause of death globally. While commonly considered a disease of smokers, common causes of COPD also include environmental pollution, infection, pre- and peri-natal life insults, and genetic predisposition [1, 2]. Current therapies are limited to reducing the burden of symptoms or exacerbations, but do not fundamentally alter the trajectory of the disease.</p>\\n</sec>\",\"PeriodicalId\":12265,\"journal\":{\"name\":\"European Respiratory Journal\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2024-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Respiratory Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.00921-2024\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.00921-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

摘 要 慢性阻塞性肺病是一种发病率越来越高、渐进性且常常使人衰弱的肺部疾病,目前是全球第三大死亡原因。虽然慢性阻塞性肺病通常被认为是吸烟者的疾病,但其常见病因还包括环境污染、感染、产前和围产期的生活损伤以及遗传易感性[1, 2]。目前的疗法仅限于减轻症状或病情加重的负担,并不能从根本上改变疾病的发展轨迹。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD
Extract

COPD is an increasingly prevalent, progressive and often debilitating lung disease, currently the third leading cause of death globally. While commonly considered a disease of smokers, common causes of COPD also include environmental pollution, infection, pre- and peri-natal life insults, and genetic predisposition [1, 2]. Current therapies are limited to reducing the burden of symptoms or exacerbations, but do not fundamentally alter the trajectory of the disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Respiratory Journal
European Respiratory Journal 医学-呼吸系统
CiteScore
27.50
自引率
3.30%
发文量
345
审稿时长
2-4 weeks
期刊介绍: The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.
期刊最新文献
European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis. Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA. Determination of loss of chromosome Y in peripheral blood cells in males with idiopathic pulmonary fibrosis. ERJ advances: epigenetic ageing and leveraging DNA methylation in chronic respiratory diseases. Perspective on WHO implementation guidance on TB infection prevention and control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1